Hints and tips:
...In previous testimony, Holmes admitted she personally added the logos of Pfizer and Schering-Plough to documents purporting to show their work together....
...The change involved adding the logos of the pharmaceutical companies Pfizer and Schering-Plough to two different reports — without the companies’ knowledge....
...and Schering-Plough....
...At other key moments, Holmes appeared anxious discussing documents that she personally altered to include the logos of the pharmaceutical companies Pfizer and Schering-Plough without their permission....
...“As these companies start selling into the US and Europe, revenues are growing and they will use that to plough funds back into research and development.”...
...BioNTech needed to make money from its first product to plough back into the business....
...There were several massive deals in 2009, including Pfizer’s purchase of Wyeth; Merck’s of Schering-Plough; and Roche’s of Genentech....
...Mr Hudson, 51, has spent his 28-year career with pharma companies including Schering-Plough, AstraZeneca and Novartis, in the US, Japan and Europe....
...A decade ago, the US pharmaceuticals company Merck paid $41bn to acquire Schering-Plough, consolidating and cutting thousands of jobs amid an industry crisis of innovation and confidence....
...The amyloid hypothesis has fallen in popularity in recent years after a string of high-profile failures from companies including Merck & Co, Eli Lilly, and AstraZeneca....
..., Roche, Novartis and Takeda Pharmaceuticals....
...Across the Hudson was New Jersey pharmaceutical firm Schering-Plough, where she worked as a brand manager “selling bunion pads and wart remover”....
...Hassan was chairman and chief executive of Schering–Plough Corporation from 2003 to 2009....
...Acalabrutinib was inherited by Merck when it bought Schering-Plough in 2009 but it later disposed of the drug....
...However, a Pfizer-Allergan tie-up, would be the first full-scale combination between two top-20 pharma groups since Pfizer bought Wyeth and Merck acquired Schering-Plough in 2009....
...MSMB’s investors included the daughter of Fred Hassan, former chief executive of drugmaker Schering Plough, according to the lawsuit....
...The Covestro IPO should enable Bayer to allocate more funds for research in its pharmaceutical drug operations....
..., now chief executive of Allergan, and Fred Hassan, the former chief executive of pharmaceuticals company Schering Plough....
...Fred Hassan, the former chief executive of Schering Plough, recently joined the board of Amgen, the investor pointed out....
...And finally, it executed a cost-saving merger with Schering-Plough during the depths of the recession. Can Takeda achieve a similar comeback?...
...global pharmaceuticals industry....
...● Related Lex note: Bayer/Merck – the right price?...
...’s $41bn for Schering-Plough and Roche’s $47bn buyout of Genentech in 2009....
...By the 1980s it had become a hub for pharmaceutical companies, including Schering-Plough, Abbott Laboratories, Eli Lilly, Merck, Pfizer, and Johnson & Johnson. Thousands of jobs were created....
...In the previous decade, companies tended to fill holes in sales through large acquisitions, such as Merck’s $41bn purchase of Schering-Plough, and Pfizer’s of Wyeth in 2009 for $68bn....
International Edition